Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 70010-780

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70010-780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Meto-100mg-100s (Meto 100mg 100s)

Metoprolol Succinate Extended-Release Tablets, USP label for 100 mg strength. The label indicates 100 tablets per package, manufactured by Granules India Limited in Hyderabad, India, for Granules Pharmaceuticals Inc., Chantilly, VA. It includes storage instructions and a barcode, with batch coding information in a separate marked area.*

FDA Label Image

Meto-200mg-100s (Meto 200mg 100s)

Label for Metoprolol Succinate Extended-Release Tablets, USP 200 mg, oral film-coated tablets. Contains 100 tablets per package. Manufactured by Granules India Limited, Hyderabad, India, and labeled for Granules Pharmaceuticals Inc., Chantilly, VA. Includes storage instructions, caution to keep out of reach of children, and a barcode with NDC 70010-783-01. Features a designated varnish area for batch coding on the label.*

FDA Label Image

Meto-25mg-100s (Meto 25mg 100s)

Label for Metoprolol Succinate Extended-Release Tablets USP, 25 mg strength. The label states a package size of 100 tablets and includes dosage information noting each tablet contains 23.75 mg metoprolol succinate equivalent to 25 mg metoprolol tartrate. Manufactured by Granules India Limited, Hyderabad, India, and labeled for Granules Pharmaceuticals Inc., Chantilly, VA. The label has storage instructions and a barcode on the upper right.*

FDA Label Image

Meto-50mg-100s (Meto 50mg 100s)

Label for Metoprolol Succinate Extended-Release Tablets, USP 50 mg, film-coated oral tablets. The label indicates a package size of 100 tablets, metoprolol succinate strength equivalent to 50 mg metoprolol tartrate. Manufactured by Granules India Limited, Hyderabad, India, and for Granules Pharmaceuticals Inc., Chantilly, VA. Includes storage instructions and warnings.*

FDA Label Image

Meto-figure.jpg (Meto Figure)

A forest plot titled 'Results for Subgroups in MERIT-HF' showing comparisons of relative risk and 95% confidence intervals for metoprolol succinate extended-release tablets versus placebo. The plot includes subgroups such as U.S., Non-U.S., NYHA class I-IV, ejection fraction levels, ischemic etiology, sex, race, myocardial infarction history, diabetes status, hypertension status, and heart rate categories. Three outcome measures are depicted: Total Mortality, Total Mortality or All-Cause Hospitalization, and Total Mortality or Hospitalization for Heart Failure, with risk favored either for metoprolol succinate or placebo.*

FDA Label Image

Meto-structure.jpg (Meto Structure)

Chemical structure of Metoprolol Succinate, depicting its molecular arrangement including phenyl, hydroxyl, and succinate components as shown in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.